Recombinant Cetuximab antibody
MALS verified
Reactivity: Human
Host: Mouse
Monoclonal
12B1E9
unconjugated
Recombinant Antibody
-
- Target See all Cetuximab products
- Cetuximab
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human
-
Host
- Mouse
-
Clonality
- Monoclonal
-
Conjugate
- This Cetuximab antibody is un-conjugated
- Purpose
- Anti-Cetuximab Antibody (12B1E9) (recommended for PK/PD, MALS verified)
- Characteristics
- Anti-idiotypic Antibodies
- Grade
- MALS verified
- Immunogen
- Anti-Cetuximab Antibody (12B1E9) (ABIN7482184) is a monoclonal antibody recombinantly expressed from human 293 cells (HEK293). The mouse monoclonal antibody is produced from a hybridoma resulting from fusion of SP2/0 myeloma and B-lymphocytes obtained from a mouse immunized with Cetuximab ADA.
- Clone
- 12B1E9
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Storage
- -20 °C
-
- Target
- Cetuximab
- Abstract
- Cetuximab Products
- Target Type
- Antibody
- Background
- Cetuximab is an epidermal growth factor receptor binding FAB. Cetuximab is composed of the Fv (variable, antigen-binding) regions of the 225 murine EGFr monoclonal antibody specific for the N-terminal portion of human EGFr with human IgG1 heavy and kappa light chain constant (framework) regions.
-
You are here:
